Absence of microsatellite instability and BRAF (V600E) mutation in testicular germ cell tumors

F M Cárcano1,2, A H Lengert3,4, D O Vidal3,4

  • 1Department of Medical Oncology, Barretos Cancer Hospital, Barretos, Brazil.

Andrology
|May 7, 2016
PubMed

Insights

Microsatellite instability (MSI) and BRAF V600E mutations were absent in all testicular germ cell tumors (TGCT) studied. This suggests these genetic alterations are not key drivers in TGCT pathogenesis or refractory disease.

Area of Science:

  • Oncology
  • Genetics
  • Molecular Biology

Background:

  • Testicular germ cell tumors (TGCT) are the most common cancer in young men.
  • Microsatellite instability (MSI), a marker of genetic instability due to DNA mismatch repair deficiency, and BRAF mutations are implicated in various cancers.
  • The role of MSI and BRAF mutations in TGCT, especially refractory cases, remains unclear with conflicting reports.

Purpose of the Study:

  • To investigate the frequency and clinical significance of MSI and BRAF mutations in TGCT.
  • To assess the potential of MSI and BRAF V600E as biomarkers or therapeutic targets in TGCT.

Main Methods:

  • DNA extraction from 150 formalin-fixed paraffin-embedded (FFPE) TGCT tissues.
  • MSI assessment using multiplex PCR for five mononucleotide repeat markers.
  • BRAF V600E mutation analysis via PCR and direct sequencing of exon 15.

Main Results:

  • A total of 133 TGCT cases were analyzed for MSI, with none exhibiting the instability phenotype.
  • Out of 132 evaluable cases, all tested negative for the BRAF V600E mutation.
  • Poor DNA quality prevented analysis in a small subset of cases (17 for MSI, 18 for BRAF).

Conclusions:

  • The study found no evidence of microsatellite instability or BRAF V600E mutations in the tested TGCT cohort.
  • These findings indicate that MSI and BRAF V600E are unlikely to be major contributors to TGCT development or treatment resistance.